CEACAMP11

Across TCGA pan-cancer cohorts, CEACAMP11 RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated CEACAMP11 data layer.

The strongest signal is observed in thymoma (THYM), where higher CEACAMP11 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated CEACAMP11 expression acts as an unfavorable survival marker, although some lineages such as UVM and SKCM show a favorable association.

THYM, LUAD, and COAD are the cancer types where CEACAMP11 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THYM	OS	Tertile	All	0.585	0.879	<.001	81	view →
LUAD	OS	Tertile	All	0.504	0.697	.003	66	view →
COAD	OS	Tertile	II,III,IV	0.571	0.863	<.001	51	view →
LUSC	DFS	Tertile	III,IV	0.010	0.754	<.001	49	view →
PCPG	DFS	Tertile	All	0.557	0.901	<.001	45	view →
STAD	DFS	Tertile	All	0.552	0.681	.009	36	view →
UVM	OS	Tertile	All	0.949	0.531	.023	30	view →
KICH	DFS	Median	III,IV	0.373	1.000	.008	22	view →
THCA	DFS	Tertile	All	0.863	0.950	<.001	18	view →
KIRP	OS	Quartile	All	0.801	0.914	.010	17	view →
ESCA	DFS	Tertile	II,III,IV	0.366	0.526	.038	6	view →
CHOL	DFS	Tertile	III,IV	0.154	0.527	.046	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

CEACAMP11–THYM (OS)

Open the THYM breakdown →